Literature DB >> 3504126

An investigation of heparinase immobilization.

H Bernstein1, V C Yang, R Langer.   

Abstract

A systematic investigation of the parameters that affect the efficiency of immobilizing heparinase onto cyanogen bromide activated crosslinked 8% agarose beads was conducted. Two experimental measures, the "fraction bound" and the "fraction retained," were used to monitor the coupling efficiency. The fraction bound is the portion of the total initial enzyme that is bound to the agarose gel. The fraction retained is the fraction of bound enzyme that is active. The product of the two measures indicates the coupling efficiency. The activity of the immobilized heparinase was measured under conditions free of both internal and external mass transfer limitations, and thus, the fraction retained represents the true immobilized enzyme activity. Increasing the degree of activation of the beads results in an increase in the fraction bound, the fraction retained, and consequently, the coupling efficiency. As the ratio of enzyme solution to gel volume increases from 1.5 to 2.2, the fraction bound remains constant but the fraction retained decreases (heparinase concentration; 0.15 mg/mL and degree of activation; 9.5 mumol of cyanate esters/g of gel). At volume ratios greater than 2.2, both the fraction bound and the fraction retained decline continuously. Changing the heparinase concentration in the coupling solution changes the coupling efficiency in a manner similar to that of the volume ratio change. When heparin is added during the coupling process, the fraction bound declines as the heparin concentration increases, whereas the fraction retained increases up to a heparin concentration of 12 mg/mL and decreases thereafter. When arginine, lysine, and glycine are used to block the unreacted cyanate ester groups after the coupling process, the immobilized heparinase shows different pH optima of 6.5, 6.9, and 7.2, respectively. Based upon these findings, a protocol to optimize heparinase immobilization is developed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3504126     DOI: 10.1007/BF02798362

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  10 in total

Review 1.  Biologic actions of heparin.

Authors:  R D Rosenberg
Journal:  Semin Hematol       Date:  1977-10       Impact factor: 3.851

2.  Immobilized heparinase: In vitro reactor model.

Authors:  H Bernstein; V C Yang; R Langer
Journal:  Biotechnol Bioeng       Date:  1987-08-05       Impact factor: 4.530

3.  Distribution of heparinase covalently immobilized to agarose: Experimental and theoretical studies.

Authors:  H Bernstein; V C Yang; R Langer
Journal:  Biotechnol Bioeng       Date:  1987-08-05       Impact factor: 4.530

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  A simplified method for cyanogen bromide activation of agarose for affinity chromatography.

Authors:  S C March; I Parikh; P Cuatrecasas
Journal:  Anal Biochem       Date:  1974-07       Impact factor: 3.365

6.  An immobilized microbial heparinase for blood deheparinization.

Authors:  R J Linhardt; C L Cooney; D Tapper; C A Zannetos; A K Larsen; R Langer
Journal:  Appl Biochem Biotechnol       Date:  1984-02       Impact factor: 2.926

7.  An enzymatic system for removing heparin in extracorporeal therapy.

Authors:  R Langer; R J Linhardt; S Hoffberg; A K Larsen; C L Cooney; D Tapper; M Klein
Journal:  Science       Date:  1982-07-16       Impact factor: 47.728

8.  Procedures for the analysis of cyanogen bromide-activated Sepharose or Sephadex by quantitative determination of cyanate esters and imidocarbonates.

Authors:  J Kohn; M Wilchek
Journal:  Anal Biochem       Date:  1981-08       Impact factor: 3.365

9.  Extracorporeal enzymatic heparin removal: use in a sheep dialysis model.

Authors:  H Bernstein; V C Yang; D Lund; M Randhawa; W Harmon; R Langer
Journal:  Kidney Int       Date:  1987-10       Impact factor: 10.612

10.  Purification and characterization of heparinase from Flavobacterium heparinum.

Authors:  V C Yang; R J Linhardt; H Bernstein; C L Cooney; R Langer
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

  10 in total
  2 in total

1.  Synthesis and characterization of positively charged tPA as a prodrug using heparin/protamine-based drug delivery system.

Authors:  J F Liang; Y T Li; M E Connell; V C Yang
Journal:  AAPS PharmSci       Date:  2000

2.  Immobilization alters heparin cleaving properties of heparinase I.

Authors:  Indu Bhushan; Alhumaidi Alabbas; Balagurunathan Kuberan; Ram B Gupta; Umesh R Desai
Journal:  Glycobiology       Date:  2017-11-01       Impact factor: 4.313

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.